|
KRIT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77846626314704E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00006677886222E-12 |
| Normal-vs-Stage2 |
6.781600E-04 |
| Normal-vs-Stage3 |
3.49664741605693E-12 |
| Normal-vs-Stage4 |
1.79170012160057E-10 |
| Stage1-vs-Stage2 |
1.637830E-01 |
| Stage1-vs-Stage3 |
2.622100E-02 |
| Stage1-vs-Stage4 |
8.460100E-02 |
| Stage2-vs-Stage3 |
8.538700E-03 |
| Stage2-vs-Stage4 |
2.002200E-02 |
| Stage3-vs-Stage4 |
9.790400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17603712826531E-14 |
| Normal-vs-AfricanAmerican |
4.381800E-04 |
| Normal-vs-Asian |
1.00920000001281E-06 |
| Caucasian-vs-AfricanAmerican |
2.148000E-01 |
| Caucasian-vs-Asian |
1.644990E-01 |
| AfricanAmerican-vs-Asian |
8.437600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.50897089163027E-12 |
| Normal-vs-Female |
5.58331159083991E-12 |
| Male-vs-Female |
4.810200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24560370298832E-11 |
| Normal-vs-Age(41-60Yrs) |
1.46469947281958E-10 |
| Normal-vs-Age(61-80Yrs) |
3.44280048913959E-10 |
| Normal-vs-Age(81-100Yrs) |
2.155300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.528400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.612800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.836800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.488600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.264200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.755200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.91479999997768E-06 |
| Classical-VS-Follicular |
2.902400E-02 |
| Classical-VS-Other |
7.155000E-01 |
| Classical-VS-Normal |
1.91135995919467E-12 |
| Tall-VS-Follicular |
2.2308000002802E-07 |
| Tall-VS-Other |
7.125800E-02 |
| Tall-VS-Normal |
1.7430501486615E-14 |
| Follicular-VS-Other |
3.361200E-01 |
| Follicular-VS-Normal |
3.229000E-04 |
| Other-VS-Normal |
4.015600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.18230039278944E-10 |
| Normal-vs-N1 |
7.29439999513914E-08 |
| N0-vs-N1 |
4.595600E-01 |
|
|
